LaTonya J Hickson1, Sanjay Chaudhary2, Amy W Williams2, John J Dillon2, Suzanne M Norby2, James R Gregoire2, Robert C Albright2, James T McCarthy2, Bjorg Thorsteinsdottir3, Andrew D Rule2. 1. Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic College of Medicine, Rochester, MN. Electronic address: hickson.latonya@mayo.edu. 2. Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN. 3. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic College of Medicine, Rochester, MN; Division of Primary Care Internal Medicine, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN.
Abstract
BACKGROUND: Recent policy clarifications by the Centers for Medicare & Medicaid Services have changed access to outpatient dialysis care at end-stage renal disease (ESRD) facilities for individuals with acute kidney injury in the United States. Tools to predict "ESRD" and "acute" status in terms of kidney function recovery among patients who previously initiated dialysis therapy in the hospital could help inform patient management decisions. STUDY DESIGN: Historical cohort study. SETTING & PARTICIPANTS: Incident hemodialysis patients in the Mayo Clinic Health System who initiated in-hospital renal replacement therapy (RRT) and continued outpatient dialysis following hospital dismissal (2006 through 2009). PREDICTOR: Baseline estimated glomerular filtration rate (eGFR), acute tubular necrosis from sepsis or surgery, heart failure, intensive care unit, and dialysis access. OUTCOMES: Kidney function recovery defined as sufficient kidney function for outpatient hemodialysis therapy discontinuation. RESULTS: Cohort consisted of 281 patients with a mean age of 64 years, 63% men, 45% with heart failure, and baseline eGFR≥30mL/min/1.73m(2) in 46%. During a median of 8 months, 52 (19%) recovered, most (94%) within 6 months. Higher baseline eGFR (HR per 10-mL/min/1.73m(2) increase eGFR, 1.27; 95% CI, 1.16-1.39; P<0.001), acute tubular necrosis from sepsis or surgery (HR, 3.34; 95% CI, 1.83-6.24; P<0.001), and heart failure (HR, 0.40; 95% CI, 0.19-0.78, P=0.007) were independent predictors of recovery within 6 months, whereas first RRT in the intensive care unit and catheter dialysis access were not. There was a positive interaction between absence of heart failure and eGFR≥30mL/min/1.73m(2) for predicting kidney function recovery (P<0.001). LIMITATIONS: Sample size. CONCLUSIONS: Kidney function recovery in the outpatient hemodialysis unit following in-hospital RRT initiation is not rare. As expected, higher baseline eGFR is an important determinant of recovery. However, patients with heart failure are less likely to recover even with a higher baseline eGFR. Consideration of these factors at hospital discharge informs decisions on ESRD status designation and long-term hemodialysis care.
BACKGROUND: Recent policy clarifications by the Centers for Medicare & Medicaid Services have changed access to outpatient dialysis care at end-stage renal disease (ESRD) facilities for individuals with acute kidney injury in the United States. Tools to predict "ESRD" and "acute" status in terms of kidney function recovery among patients who previously initiated dialysis therapy in the hospital could help inform patient management decisions. STUDY DESIGN: Historical cohort study. SETTING & PARTICIPANTS: Incident hemodialysis patients in the Mayo Clinic Health System who initiated in-hospital renal replacement therapy (RRT) and continued outpatient dialysis following hospital dismissal (2006 through 2009). PREDICTOR: Baseline estimated glomerular filtration rate (eGFR), acute tubular necrosis from sepsis or surgery, heart failure, intensive care unit, and dialysis access. OUTCOMES: Kidney function recovery defined as sufficient kidney function for outpatient hemodialysis therapy discontinuation. RESULTS: Cohort consisted of 281 patients with a mean age of 64 years, 63% men, 45% with heart failure, and baseline eGFR≥30mL/min/1.73m(2) in 46%. During a median of 8 months, 52 (19%) recovered, most (94%) within 6 months. Higher baseline eGFR (HR per 10-mL/min/1.73m(2) increase eGFR, 1.27; 95% CI, 1.16-1.39; P<0.001), acute tubular necrosis from sepsis or surgery (HR, 3.34; 95% CI, 1.83-6.24; P<0.001), and heart failure (HR, 0.40; 95% CI, 0.19-0.78, P=0.007) were independent predictors of recovery within 6 months, whereas first RRT in the intensive care unit and catheter dialysis access were not. There was a positive interaction between absence of heart failure and eGFR≥30mL/min/1.73m(2) for predicting kidney function recovery (P<0.001). LIMITATIONS: Sample size. CONCLUSIONS: Kidney function recovery in the outpatient hemodialysis unit following in-hospital RRT initiation is not rare. As expected, higher baseline eGFR is an important determinant of recovery. However, patients with heart failure are less likely to recover even with a higher baseline eGFR. Consideration of these factors at hospital discharge informs decisions on ESRD status designation and long-term hemodialysis care.
Authors: Ann M O'Hare; Adam Batten; Nilka Ríos Burrows; Meda E Pavkov; Leslie Taylor; Indra Gupta; Jeff Todd-Stenberg; Charles Maynard; Rudolph A Rodriguez; Fliss E M Murtagh; Eric B Larson; Desmond E Williams Journal: Am J Kidney Dis Date: 2012-02-04 Impact factor: 8.860
Authors: Nattachai Srisawat; Xiaoyan Wen; Minjae Lee; Lan Kong; Michele Elder; Melinda Carter; Mark Unruh; Kevin Finkel; Anitha Vijayan; Mohan Ramkumar; Emil Paganini; Kai Singbartl; Paul M Palevsky; John A Kellum Journal: Clin J Am Soc Nephrol Date: 2011-07-14 Impact factor: 8.237
Authors: Kelly V Liang; Francis Pike; Christos Argyropoulos; Lisa Weissfeld; Jeffrey Teuteberg; Mary Amanda Dew; Mark L Unruh Journal: Am J Kidney Dis Date: 2011-05-06 Impact factor: 8.860
Authors: Lennart G Bongartz; Branko Braam; Carlo A Gaillard; Maarten J Cramer; Roel Goldschmeding; Marianne C Verhaar; Pieter A Doevendans; Jaap A Joles Journal: Am J Physiol Renal Physiol Date: 2012-08-22
Authors: Paul M Palevsky; Jane Hongyuan Zhang; Theresa Z O'Connor; Glenn M Chertow; Susan T Crowley; Devasmita Choudhury; Kevin Finkel; John A Kellum; Emil Paganini; Roland M H Schein; Mark W Smith; Kathleen M Swanson; B Taylor Thompson; Anitha Vijayan; Suzanne Watnick; Robert A Star; Peter Peduzzi Journal: N Engl J Med Date: 2008-05-20 Impact factor: 91.245
Authors: Balwinder Singh; Amandeep Singh; Adil Ahmed; Gregory A Wilson; Brian W Pickering; Vitaly Herasevich; Ognjen Gajic; Guangxi Li Journal: Mayo Clin Proc Date: 2012-09 Impact factor: 7.616
Authors: LaTonya J Hickson; Bjorg Thorsteinsdottir; Priya Ramar; Megan S Reinalda; Cynthia S Crowson; Amy W Williams; Robert C Albright; Macaulay A Onuigbo; Andrew D Rule; Nilay D Shah Journal: Nephron Date: 2018-01-09 Impact factor: 2.847
Authors: Diana L Vork; Terry D Schneekloth; Adam C Bartley; Lisa E Vaughan; Maria I Lapid; Sheila G Jowsey-Gregoire; Ziad M El-Zoghby; Sandra M Herrmann; Cheryl L Tran; Robert C Albright; LaTonya J Hickson Journal: Mayo Clin Proc Date: 2018-03 Impact factor: 7.616
Authors: Joy Chieh-Yu Chen; Bjorg Thorsteinsdottir; Lisa E Vaughan; Molly A Feely; Robert C Albright; Macaulay Onuigbo; Suzanne M Norby; Christy L Gossett; Margaret M D'Uscio; Amy W Williams; John J Dillon; LaTonya J Hickson Journal: Clin J Am Soc Nephrol Date: 2018-07-19 Impact factor: 8.237
Authors: Jorge Cerdá; Kathleen D Liu; Dinna N Cruz; Bertrand L Jaber; Jay L Koyner; Michael Heung; Mark D Okusa; Sarah Faubel Journal: Clin J Am Soc Nephrol Date: 2015-07-02 Impact factor: 8.237
Authors: Abdurrahman M Hamadah; Lynn M Beaulieu; John W Wilson; Timothy R Aksamit; James R Gregoire; Amy W Williams; John J Dillon; Robert C Albright; Macaulay Onuigbo; Venkateshwaran K Iyer; LaTonya J Hickson Journal: Nephron Date: 2016-02-10 Impact factor: 2.847
Authors: LaTonya J Hickson; Sara M Negrotto; Macaulay Onuigbo; Christopher G Scott; Andrew D Rule; Suzanne M Norby; Robert C Albright; Edward T Casey; John J Dillon; Patricia A Pellikka; Sorin V Pislaru; Patricia J M Best; Hector R Villarraga; Grace Lin; Amy W Williams; Vuyisile T Nkomo Journal: J Am Coll Cardiol Date: 2016-03-15 Impact factor: 24.094
Authors: Benjamin J Lee; Alan S Go; Rishi Parikh; Thomas K Leong; Thida C Tan; Sophia Walia; Raymond K Hsu; Kathleen D Liu; Chi-Yuan Hsu Journal: Kidney Int Date: 2018-01-15 Impact factor: 10.612
Authors: Edward D Siew; Sharidan K Parr; Khaled Abdel-Kader; Svetlana K Eden; Josh F Peterson; Nisha Bansal; Adriana M Hung; James Fly; Ted Speroff; T Alp Ikizler; Michael E Matheny Journal: J Am Soc Nephrol Date: 2015-08-11 Impact factor: 10.121
Authors: Ana R Fernandes; Márcio S R Viegas; Elsa Q Soares; Sofia S Coelho; Patricia Valério; José C Barreto; José M Vinhas Journal: Int Urol Nephrol Date: 2017-10-11 Impact factor: 2.370